Beta společnosti OncoSec Medical Inc
Jaká je hodnota metriky Beta společnosti OncoSec Medical Inc?
Hodnota metriky Beta společnosti OncoSec Medical Inc je 0.00
Jaká je definice metriky Beta?
BETA koeficient vyjadřuje, zda je akcie více či méně volatilní než trh jako celek. Beta menší než 1 znamená, že akcie jsou méně volatilní než trh, zatímco beta větší než 1 znamená, že akcie jsou volatilnější. Volatilita se měří pomocí fluktuace ceny akcie.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností OncoSec Medical Inc
Čemu se věnuje společnost OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Firmy s metrikou beta podobnou společnosti OncoSec Medical Inc
- Hodnota metriky Beta společnosti Vision Marine Technologies je 0.00
- Hodnota metriky Beta společnosti Ely Gold Royalties je 0.00
- Hodnota metriky Beta společnosti Glacier Lake Resources je 0.00
- Hodnota metriky Beta společnosti Magnum Mining and Exploration je 0.00
- Hodnota metriky Beta společnosti Africa Opportunity Fund je 0.00
- Hodnota metriky Beta společnosti Fulcrum Utility Services je 0.00
- Hodnota metriky Beta společnosti OncoSec Medical Inc je 0.00
- Hodnota metriky Beta společnosti Gullewa je 0.00
- Hodnota metriky Beta společnosti S.A.L. Steel je 0.00
- Hodnota metriky Beta společnosti Andina Acquisition III je 0.00
- Hodnota metriky Beta společnosti Andina Acquisition III je 0.00
- Hodnota metriky Beta společnosti Brilliant Acquisition je 0.00
- Hodnota metriky Beta společnosti Indokem je 0.00